Combined characterization of a pituitary adenoma and a subcutaneous lipoma in a MEN1 patient with a whole gene deletion

Cancer Genetics

Volumn 204, Issue 6, 2011, Pages 309-315

  Rusconi, Daniela ^a   Valtorta, Emanuele ^a   Rodeschini, Ornella ^a   Giardino, Daniela ^a   Lorenzo, Iughetti ^b   Predieri, Barbara ^b   Losa, Marco ^c   Larizza, Lidia ^a,d   Finelli, Palma ^a,d  

^a ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

ACGH; FISH; Lipoma; MEN1; Pituitary adenoma

Indexed keywords

ADULT; ARTICLE; CARCINOGENESIS; CASE REPORT; CHROMOSOME 11Q; CHROMOSOME DELETION; CHROMOSOME TRANSLOCATION; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOGENETICS; DNA DETERMINATION; FEMALE; GENE; GENE DELETION; GENE INACTIVATION; HETEROZYGOSITY LOSS; HUMAN; MEN1 GENE; MULTIPLE ENDOCRINE NEOPLASIA; PANCREAS DISEASE; PARATHYROID HYPERPLASIA; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; PROLACTINOMA; SKIN TUMOR; SUBCUTANEOUS LIPOMA; FLUORESCENCE IN SITU HYBRIDIZATION; GENETICS; HYPOPHYSIS TUMOR; KARYOTYPING; LIPOMA; MULTIPLE CANCER;

COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; GENE DELETION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LIPOMA; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; NEOPLASMS, MULTIPLE PRIMARY; PITUITARY NEOPLASMS; SKIN NEOPLASMS; YOUNG ADULT;

EID: 80052814512     PISSN: 22107762     EISSN: 22107770     Source Type: Journal    
DOI: 10.1016/j.cancergen.2011.03.006     Document Type: Article

References (35)

1. Balogh K., Patócs A., Majnik J., et al. Unusual presentation of multiple endocrine neoplasia type 1 in a young woman with a novel mutation of the MEN1 gene. J Human Genet 2004, 49:380-386.
2. Marini F., Falchetti A., Del Monte F., et al. Multiple endocrine neoplasia type 1. Orphanet J Rare Dis 2006, 2:1-38.
3. Peppa M., Boutati E., Kamakari S., et al. Novel germline mutations of the MEN1 gene in Greek families with multiple endocrine neoplasia type 1. Clin Endocrinol 2008, 70:75-81.
4. Hai N., Aoki N., Shimatsu A., et al. Clinical features of multiple endocrine neoplasia type 1 (MEN1) phenocopy without germline MEN1 gene mutations: analysis of 20 Japanese sporadic cases with MEN1. Clin Endocrinol 2000, 52:509-518.
5. Kouvaraki M.A., Lee J.E., Shapiro S.E., et al. Genotype-phenotype analysis in multiple endocrine neoplasia type 1. Arch Surgery 2002, 137:641-647.
6. Chakrabarti R., Srivatsan E.S., Wood T.F., et al. Deletion mapping of endocrine tumors localizes a second tumor suppressor gene on chromosome band 11q13. Genes Chromosomes Cancer 1998, 22:130-137.
7. Cavaco B.M., Domingues R., Bacelar M.C., et al. Mutational analysis of Portuguese families with multiple endocrine neoplasia type 1 reveals large germline deletions. Clin Endocrinol 2002, 56:465-473.
8. Brandi M.L., Gagel R.F., Angeli A., et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metabol 2001, 86:5658-5671.
9. Agarwal S.K., Lee Burns A., Sukhodolets K.E., et al. Molecular pathology of the MEN1 gene. Ann NY Acad Sci 2004, 1014:189-198.
10. Vidal A., Iglesias M.J., Fernández B., et al. Cutaneous lesions associated to multiple endocrine neoplasia syndrome type 1. J Eur Acad Dermatol Venereol 2008, 22:835-838.
11. Chandrasekharappa S.C., Guru S.C., Manickam P., et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 1997, 276:404-407.
12. Agarwal S.K., Kennedy P.A., Scacheri P.C., et al. Menin molecular interactions: insights into normal functions and tumorigenesis. Hormone Metabol Res 2005, 37:369-374.
13. Balogh K., Rácz K., Patócs A., Hunyady L. Menin and its interacting proteins: elucidation of menin function. Trends Endocrinol Metabol 2006, 17:357-364. review.
14. Lemos M.C., Thakker R.V. Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene. Human Mutation 2008, 29:22-32.
15. Yang Y., Hua X. In search of tumor suppressing functions of menin. Mol Cell Endocrinol 2007, 265/266:34-41.
16. Pannett A.A., Thakker R.V. Somatic mutations in MEN type 1 tumors, consistent with the Knudson "two-hit" hypothesis. J Clin Endocrinol Metabol 2001, 86:4371-4374.
17. Stenson P.D., Ball E.V., Mort M., et al. Human Gene Mutation Database (HGMD): 2003 update. Human Mutat 2003, 21:577-581.
18. Owens M., Ellard S., Vaidya B. Analysis of gross deletions in the MEN1 gene in patients with multiple endocrine neoplasia type 1. Clin Endocrinol 2008, 68:350-354.
19. Fukuuchi A., Nagamura Y., Yaguchi H., et al. A whole MEN1 gene deletion flanked by Alu repeats in a family with multiple endocrine neoplasia type 1. J Japan Clin Oncol 2006, 36:739-744.
20. Kikuchi M., Ohkura N., Yamaguchi K., et al. Gene dose mapping delineated boundaries of a large germline deletion responsible for multiple endocrine neoplasia type 1. Cancer Lett 2004, 208:81-88.
21. Ellard S., Hattersley A.T., Brewer C.M., Vaidya B. Detection of an MEN1 gene mutation depends on clinical features and supports current referral criteria for diagnostic molecular genetic testing. Clin Endocrinol 2005, 62:169-175.
22. Cardinal J.W., Bergman L., Hayward N., et al. A report of a national mutation testing service for the MEN1 gene: clinical presentations and implications for mutation testing. J Med Genet 2005, 42:69-74.
23. Klein R.D., Salih S., Bessoni J., Bale A.E. Clinical testing for multiple endocrine neoplasia type 1 in a DNA diagnostic laboratory. Genetics in Medicine: official journal of the American College of Medical Genetics 2005, 7:131-138.
24. ISCN: An international System for Human Cytogenetic Nomenclature 2009, S. Karger, Basel. L.G. Shaffer, M.L. Slovak, L.J. Campbell (Eds.).
25. Lichter P., Tang C.J., Call K., et al. High-resolution mapping of human chromosome 11 by in situ hybridization with cosmid clones. Science 1990, 247:64-69.
26. Lichter P., Cremer T. Chromosome analysis by non-isotopic in situ hybridization. Human Cytogenetics - A Practical Approach 1992, 157-192. University Press, Oxford. E. Rooney, B.H. Czipolkowski (Eds.).
27. Trautmann K., Thakker R.V., Ellison D.W., Ibrahim A., Lees P.D., Harding B., et al. Chromosomal aberrations in sporadic pituitary tumors. Int J Cancer 2001, 91:809-814.
28. Pack S.D., Qin L.X., Pak E., et al. Common genetic changes in hereditary and sporadic pituitary adenomas detected by comparative genomic hybridization. Genes Chromosomes Cancer 2005, 43:72-82.
29. Daniely M., Aviram A., Adams E.F., Buchfelder M., Barkai G., Fahlbusch R., et al. Comparative genomic hybridization analysis of nonfunctioning pituitary tumors. J Clin Endocrinol Metabol 1998, 83:1801-1805.
30. Harada K., Nishizaki T., Ozaki S., et al. Cytogenetic alterations in pituitary adenomas detected by comparative genomic hybridization. Cancer Genet Cytogenet 1999, 112:38-41.
31. Finelli P., Giardino D., Rizzi N., et al. Non-random trisomies of chromosomes 5, 8 and 12 in the prolactinoma sub-type of pituitary adenomas: conventional cytogenetics and interphase FISH study. Int J Cancer 2000, 86:344-350.
32. Szymas J., Schluens K., Liebert W., Petersen I. Genomic instability in pituitary adenomas. Pituitary 2002, 5:211-219.
33. Finelli P., Pierantoni G.M., Giardino D., et al. The high mobility group A2 gene is amplified and overexpressed in human prolactinomas. Cancer Res 2002, 62:2398-2405.
34. Kost-Alimova M., Imreh S. Modeling non-random deletions in cancer. Sem Cancer Biol 2007, 17:19-30.
35. Durkin S.G., Glover T.W. Chromosome fragile sites. Annu Rev Genet 2007, 41:169-192. review.